GAVI

GAVI
Name	GAVI
Formation	2000
Type	Public–private global health partnership
Headquarters	Geneva, Switzerland
Key people	José Manuel Barroso (Chair), Seth Berkley (former CEO)
Website	www.gavi.org

GAVI. The GAVI Alliance, originally known as the Global Alliance for Vaccines and Immunisation, is an international public-private partnership focused on increasing access to immunization in low-income countries. Launched at the World Economic Forum in 2000, its core mission is to save lives and protect health by improving equitable and sustainable use of vaccines. The alliance brings together key stakeholders from the public and private sectors, including national governments, the World Health Organization, UNICEF, the World Bank, philanthropic organizations, vaccine manufacturers, and civil society.

History and formation

GAVI was founded in 2000, an initiative born from a growing recognition of a significant immunization gap between wealthy and developing nations. Its creation was championed by key figures and institutions, including the Bill & Melinda Gates Foundation, which provided a seminal founding grant, and was formally launched at the World Economic Forum in Davos. The formation was a direct response to stagnating global vaccination rates and the need for a new, coordinated mechanism to accelerate the introduction of new and underused vaccines. Early leadership involved prominent individuals such as former World Bank President James Wolfensohn and the foundation's co-founder, Bill Gates.

Mission and objectives

The primary mission is to save children’s lives and protect people’s health by increasing access to immunization in the world’s poorest countries. Its strategic objectives focus on accelerating the uptake and equitable delivery of new and underused vaccines, strengthening health systems to deliver immunization, and shaping vaccine markets to ensure sustainability, affordability, and supply security. A central goal is to support the immunization targets of the Sustainable Development Goals, particularly in reducing child mortality. The alliance also emphasizes improving vaccine coverage and introducing vaccines against major diseases like pneumonia, rotavirus, and human papillomavirus.

Governance and structure

The alliance is governed by a Board that sets its strategic direction and policies. This Board includes representatives from partner organizations such as the World Health Organization, UNICEF, the World Bank, and implementing country governments, as well as independent individuals, philanthropic partners like the Bill & Melinda Gates Foundation, and the vaccine industry. Day-to-day operations are managed by a Secretariat headquartered in Geneva, Switzerland. The governance framework is designed to ensure representation from its diverse stakeholders, with committees overseeing finance, audit, and program policy.

Funding and financial model

GAVI is funded through donor pledges from sovereign nations, private foundations, and corporate partners, channeled through a central funding mechanism. Major public donors have included the United Kingdom, the United States, Norway, and the European Commission. A pioneering aspect of its financial model is the use of innovative finance instruments, such as the International Finance Facility for Immunisation (IFFIm), which issues bonds on capital markets backed by long-term donor commitments. The alliance also co-finances vaccines with eligible countries to promote ownership and sustainability, and it negotiates directly with pharmaceutical companies like Pfizer and GlaxoSmithKline to secure lower vaccine prices.

Programs and impact

Core programs include supporting the introduction of vaccines against diseases such as HPV, yellow fever, measles, and meningitis in eligible countries. A major initiative is the COVAX facility, co-led with the World Health Organization and the Coalition for Epidemic Preparedness Innovations (CEPI), to ensure global equitable access to COVID-19 vaccines. The alliance reports having immunized over 888 million children and prevented more than 15 million future deaths since its inception. Its work has significantly contributed to the reduction of child mortality and the control of outbreaks, such as those of cholera in emergency settings.

Partnerships and stakeholders

The alliance operates as a multi-stakeholder partnership, with core founding partners being the World Health Organization, UNICEF, the World Bank, and the Bill & Melinda Gates Foundation. It collaborates closely with the vaccine manufacturing sector, including companies in both industrialized and emerging markets. Implementing country governments are critical partners, defining their immunization needs through comprehensive multi-year plans. Other key stakeholders include research institutes, civil society organizations, and faith-based groups that assist in community engagement and delivery.

Criticism and challenges

The alliance has faced criticism over issues of transparency and the perceived influence of private sector partners, particularly pharmaceutical corporations, on its agenda. Some public health advocates have argued that its model can create dependency and undermine the development of local vaccine production capacity in Africa and other regions. Operational challenges include ensuring cold chain logistics in remote areas, addressing vaccine hesitancy, and navigating complex political environments in fragile states. The immense pressure and inequities revealed during the COVID-19 pandemic, particularly through the COVAX initiative, highlighted difficulties in achieving truly equitable global distribution amidst vaccine nationalism and supply constraints.

Category:Global health organizations Category:Vaccination